Teva Pharmaceutical Industries | TEVA - Cost Of Sales


Teva Pharmaceutical Industries reported $2.06B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Aspen Pharmacare ZAR 9.63B 3.1B Dec/2025
Cipla INR 29.1B 1.16B Dec/2025
Dr.Reddys Laboratories INR 36.16B 3.75B Dec/2025
Guangzhou Baiy CNY 14.28B 2.29B Dec/2025
Jiangsu Hengrui CNY 1.17B 86.74M Dec/2025
Kalbe Farma IDR 5.46T 523.94B Sep/2025
Richter Gedeon HUF 71.32B 1.01B Sep/2025
Sh Fosun Pharma CNY 5.57B 492.91M Dec/2025
Sun Pharmaceuticals INR 36.77B 348M Dec/2025
Teva Pharmaceutical Industries USD 2.06B 120M Dec/2025